Research output

Publications

Peer-reviewed studies, conference work, and scholarly contributions advancing translational medicine and immuno-oncology.

Publication Statistics

0
Total Publications
0
Journal Articles
0
Conference Papers
0
Books/Chapters
0
High Impact

Filter Publications

Select journals from the dropdown to filter publications

Showing 216 of 216 publications

2026

8 publications
2026Journal

Neoadjuvant pembrolizumab with therapeutic DNA vaccine reshape intratumoral immunity in a phase 2 trial of HPV-positive HNSCC

Kim HR, Koh JY, Kim CG, Hong MH, Hong HJ, Kim D, Sim NS, Yoon SO, et al.

Journal: Cancer Research

Volume: 86(7_Supplement), 6708-6708

2026Journal

Sarcopenia Predicts Outcome After Chemoimmunotherapy, Not Chemotherapy, in Advanced Lung Cancer: Single-Centre Retrospective Study

Lee H, Kim CG, Han S, Park SK, Yoon HI, Kim KH, Shim HS, Hong MH, et al.

Journal: Journal of Cachexia, Sarcopenia and Muscle

Volume: 17(2), e70243

2026Journal

Circulating Tumor Cell-based Molecular Responses Stratify EGFR-TKI Efficacy in Patients with EGFR-Mutant Lung Cancer

Lee S, Kim C, Kim CG, Hong MH, Han M, Son W, Kim G, Woo HJ, Shin HY, et al.

Journal: Cancer Research and Treatment

Volume: ,

2026Journal

EpCAM+ Extracellular Vesicle PD-L1 Dynamics as a Predictive Biomarker of Immune Checkpoint Blockade Response

Mun B, Kim J, Kim CG, Go S, Han M, Ouck Y, Jang S, Son SU, Kim G, et al.

Journal: Advanced Science

Volume: , e76389

2026Journal

Expansion of circulating NKG7+ cytotoxic CD4+ T cells as a predictor of response to PD-1 blockade in recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC)

Kim CG, Kim J, Hong M, Kim G, Kim D, Hong MH, Yeo JH, Yoon SO, et al.

Journal: Journal of Clinical Oncology

Volume: 44(16_suppl), 6043-6043

2026Journal

High-dimensional immune profiling of peripheral blood identifies immune correlates of anti-PD-1/PD-L1 resistance in oncogenic driver mutation-positive NSCLC

Kim KH, Han M, Park GW, Hong MH, Kim G, Lee BH, Son W, Kim J, Go S, et al.

Journal: Frontiers in Immunology

Volume: 17, 1829816

2026Journal

Atezolizumab and bevacizumab plus chemotherapy versus chemotherapy in non-small cell lung cancer after tyrosine kinase inhibitor failure

Hong M, Choi J, Lee S, Sang YB, Hong MH, Yeo JH, Kim JH, Yoon S, et al.

Journal: Therapeutic Advances in Medical Oncology

Volume: 18, 17588359261458751

2026Journal

Exploratory Biomarker Analysis of Abemaciclib in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma With Dysregulated CDK4/6 Pathway

Park, Joo-hwan; Ahn, Hee Kyung; Kim, Hye Ryun; Kim, Soyeon; Park, Keon-uk; Yun, Tak; Kim, Hyo Jung; Lee, Sang-cheol; Cho, Sang Hee; Park, Sang-gon; Keam, Bhumsuk; Yun, Hwan Jung

Journal: HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Volume: ,

2025

11 publications
2025Journal

Phase II study of lazertinib and pemetrexed in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer with leptomeningeal metastases: the KCSG LU 21-01, LAZARUS study

Jung, Hyun Ae; Kim, Tae Min; Kim, Hye Ryun; Kim, Chang Gon; Ahn, Hee Kyung; Lee, Youngjoo; Kim, Yu Jung; Kim, Miso; Youk, Jeonghwan; Sun, Jong-Mu; Lee, Se-Hoon; Ahn, Jin Seok; Kim, Dong-Wan; Ahn, Myung-Ju; Keam, Bhumsuk

Journal: LUNG CANCER

Volume: 210, 108809

DOI:10.1016/j.lungcan.2025.108809

2025Journal

Single‐cell multi‐omics reveals tumor microenvironment factors underlying poor immunotherapy responses in ALK‐positive lung cancer

Seungbyn Baek, Euijeong Sung, Gamin Kim, Min Hee Hong, Chang Young Lee, Hyo Sup Shim, Seong Yong Park, Hye Ryun Kim, Insuk Lee

Journal: Cancer Communications

Volume: ,

2025Journal

Preclinical investigation of anti-tumor efficacy of allogeneic natural killer cells combined with cetuximab for head and neck squamous cell carcinoma

Chaeyeon Kim, Mina Han, Gamin Kim, Wonrak Son, Jeongah Kim, Minchan Gil, Yong-Hee Rhee, Nam Suk Sim, Chang Gon Kim, Hye Ryun Kim

Journal: Cancer Immunology, Immunotherapy

Volume: ,

2025Journal

Circulating tumor cell-based molecular responses stratify EGFR-TKI efficacy in EGFR-mutant lung cancer patients

Seoyoung Lee, Chaeyeon Kim, Chang Gon Kim, Min Hee Hong, Mina Han, Wonrak Son, Gamin Kim, Minseok Kim, Hye Ryun Kim

Journal: Cancer Research

Volume: 85,

2025Journal

Comparative single‐cell analysis of esophageal cancer subtypes reveals tumor microenvironment distinctions explaining varied immunotherapy responses

Seungbyn Baek, Junha Cha, Min Hee Hong, Gamin Kim, Yoon Woo Koh, Dahee Kim, Wonrak Son, Chan‐Young Ock, Seungeun Lee, Martin Hemberg, Seong Yong Park, Hye Ryun Kim, Insuk Lee

Journal: Cancer Communications

Volume: 45, 1194

2025Journal

4-1BB+ Tregs and inhibitory progenitor exhausted T cells confer resistance to anti-PD-L1 and anti-CTLA-4 combination therapy

Junha Cha, Chang Gon Kim, Nam Suk Sim, Gamin Kim, Wonrak Son, Dahee Kim, Yurim Jung, Hyun Jun Hong, Hae Been Lee, Jaehyung Kim, Jinna Kim, Sun Och Yoon, Seokhyeong Go, Jeongah Kim, Euijung Seong, Seungbyn Baek, Kyung Hwan Kim, Min Hee Hong, Yoon Woo Koh, Insuk Lee, Hye Ryun Kim

Journal: Cell Reports Medicine

Volume: ,

2025Journal

Identifying predictive markers of head and neck squamous cell carcinoma in an umbrella trial (KCSG HN 15-16 TRIUMPH trial)

Hwang S, Hong MH, Shin SH, Yun T, Lee KW, Kim JH, Ahn MJ, Keam B, Lee HW, Kim MK, Yun HJ, Kim Y, Kim HJ, Cho SH, An HJ, Oh SY, Park SG, Koh YW, Ahn HK, Kwon JH, Lee YG, Park KU, Hwang IG, Kim SB, Kim S, Kim HR

Journal: ESMO open

Volume: ,

DOI:10.1016/j.esmoop.2025.105772

Medium Impact
2025Journal

An open-label, phase IB/II study of abemaciclib with paclitaxel for tumors with CDK4/6 pathway genomic alterations

Kim KH, Park C, Beom SH, Kim MH, Kim CG, Kim HR, Jung M, Shin SJ, Rha SY, Kim HS

Journal: ESMO Open

Volume: 10(2), 104106

DOI:10.1016/j.esmoop.2024.104106

High Impact
2025Journal

Single-cell multi-omics reveals tumor microenvironment factors underlying poor immunotherapy responses in ALK-positive lung cancer

Baek SB, Sung E, Kim G, Hong MH, Lee CY, Shim HS, Park SY, Kim HR, Lee I

Journal: Cancer Communications

Volume: 45(4), 422-427

DOI:10.1002/cac2.12658

High Impact
2025Journal

Th1-poised naive CD4 T cell subpopulation reflects anti-tumor immunity and autoimmune disease

Yoon JW, Kim KM, Cho S, Cho MJ, Park S, Hwang D, Kim HR, Park SH, Cho JH, Jeong H, Choi JM

Journal: Nature Communications

Volume: 16(1), 1962

DOI:10.1038/s41467-025-57237-3

High Impact
2025Journal

Association of thyroid radiation dose with thyroid dysfunction in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy followed by maintenance immunotherapy

Yang GW, Yoon HI, Lim SM, Hong MH, Cho JH, Lee CL, Cho BC, Kim HR, Kim KH

Journal: Lung Cancer

Volume: 204, 108574

DOI:10.1016/j.lungcan.2025.108574

High Impact

2024

9 publications
2024Journal

Radiomics and PD-L1 expression predict immunotherapy benefits in patients with head and neck squamous cell carcinoma

Sim Y, Sohn B, Kim S, Kim HR, Hong MH, Kim J, Lee SK, Lim SM

Journal: Future Oncology

Volume: 20(36), 2869-2878

DOI:10.1080/14796694.2024.2342226

Medium Impact
2024Journal

Real-World Outcomes with Lurbinectedin in Second Line and Beyond for Extensive Stage Small Cell Lung Cancer in Korea

Shim JS, Kim Y, Yuh T, Lee JB, Kim HR, Hong MH, Cho BC, Lim SM

Journal: Lung Cancer: Targets and Therapy

Volume: 15, 149-159

DOI:10.2147/LCTT.S485320

Medium Impact
2024Journal

Neoadjuvant chemotherapy followed by definitive local treatment in locally advanced sinonasal squamous cell carcinoma

Kim J, Hong MH, Kim HR, Lim SM, Kim CG, Kim DH, Sim NS, Hong HJ, Koh YW, Kim SH, Wee CW, Lee CG, Keum KC, Kim CH, Kim KH

Journal: Frontiers in Oncology

Volume: 14, 1488066

DOI:10.3389/fonc.2024.1488066

Medium Impact
2024Journal

Radiomics and PD-L1 expression predict immunotherapy benefits in patients with head and neck squamous cell carcinoma

Sim Y, Sohn B, Kim S, Kim HR, Hong MH, Kim J, Lee SK, Lim SM

Journal: Future Oncology

Volume: 20(36), 2869-2878

DOI:10.1080/14796694.2024.2342226

Medium Impact
2024Journal

Analysis of Response and Progression Patterns of Tyrosine Kinase Inhibitors in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Post Hoc Analysis of Two KCSG Phase II Trials

Kim Y, Keam B, Kang EJ, Kim JS, Kim HR, Lee KW, Kwon JH, Lee KE, Yang Y, Choi YH, Kim MK, Ji JH, Yun T, Choi MY, Lee KH, Kim SB, Ahn MJ

Journal: Cancer Research and Treatment

Volume: 56(4), 1068-1076

DOI:10.4143/crt.2024.008

High Impact
2024Journal

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with oncogene-addicted metastatic non-small-cell lung cancer

Lee SH, Menis J, Kim TM, Kim HR, Zhou C, Kurniawati SA, Prabhash K, Hayashi H, Lee DD-W, Imasa MS, Teh YL, Yang JC-H, Reungwetwattana T, Sriuranpong V, Wu C-E, Ang Y, Sabando M, Thiagarajan M, Mizugaki H, Noronha V, Yulianti M, Zhang L, Smyth E, Yoshino T, Park JO, Pentheroudakis G, Park S, Peters S, Ahn JB, Popat S

Journal: ESMO Open

Volume: 9(12), 103996

DOI:10.1016/j.esmoop.2024.103996

Medium Impact
2024Journal

Lazertinib in EGFR-Variant Non-Small Cell Lung Cancer With CNS Failure to Prior EGFR Tyrosine Kinase Inhibitors: A Nonrandomized Controlled Trial

Hong MH, Choi YJ, Ahn HK, Lim SM, Keam B, Kim DW, Kim TM, Youk J, Kim YJ, Hwang S, Kim S, Kim JW, Kim HR, Kang JH

Journal: JAMA Oncology

Volume: 10(10), 1342-1351

DOI:10.1001/jamaoncol.2024.2640

High Impact
2024Journal

A conserved pilin from uncultured gut bacterial clade TANB77 enhances cancer immunotherapy

Kim CY, Park DJ, Ahn BC, Baek SB, Hong MH, Nguyen LT, Hwang SH, Kim N, Podlesny D, Orakov A, Schudoma C, Robbani SM, Shim HS, Yoon HI, Lee CY, Park SY, Yong D, Han M, Bork P, Kim BC, Ha SJ, Kim HR, Lee I

Journal: Nature Communications

Volume: 15(1), 9847

DOI:10.1038/s41467-024-54278-9

High Impact
2024Journal

Personalized Biomarker-Based Umbrella Trial for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: KCSG HN 15-16 TRIUMPH Trial

Keam B, Hong MH, Shin SH, Heo SG, Kim JE, Ahn HK, Lee YG, Park KU, Yun T, Lee KW, Kim SB, Lee SC, Kim MK, Cho SH, Oh SY, Park SG, Hwang S, Nam BH, Kim S, Kim HR, Hwan JY

Journal: Journal of Clinical Oncology

Volume: 42(15), 1789-1801

DOI:10.1200/JCO.22.02786

High Impact

2023

11 publications
2023Journal

The prognostic value of comprehensive geriatric assessment on the management of older patients with small cell lung cancer

Chun YJ, Kim KJ, Lee JY, Choi JW, Kim TH, Kim HR, Cho BC, Hong MH, Kim CO

Journal: Korean Journal of Internal Medicine

Volume: ,

Medium Impact
2023Journal

Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC

Kim HR, Awad MM, Navarro A, Gottfried M, Peters S, Csoszi T, Cheema PK, Rodriguez-Abreu D, Wollner M, Yang JC, Mazieres J, Orlandi FJ, Luft A, Gumus M, Kato T, Kalemkerian GP, Luo Y, Santorelli ML, Pietanza MC, Rudin CM

Journal: JTO Clinical and Research Reports

Volume: 4(11), 100572

DOI:10.1016/j.jtocrr.2023.100572

High Impact
2023Conference

Personalized Biomarker-Based Umbrella Trial for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: KCSG HN 15-16 TRIUMPH Trial

Keam B, Hong MH, Shin SH, Heo SG, Kim JE, Ahn HK, Lee YG, Park KU, Yun T, Lee KW, Kim SB, Lee SC, Kim MK, Cho SH, Oh SY, Park SG, Hwang S, Nam BH, Kim S, Kim HR, Hwan JY

Conference:

Location:

Type:

2023Conference

Dynamic change of immune phenotype assessed by AI-powered analysis of tumor-infiltrating lymphocytes during neoadjuvant durvalumab with or without tremelimumab in head and neck squamous cell carcinoma

Kim H, Koh YW, Hong HJ, Kim DH, Sim NS, Hong MH, Kim CG, Lee C, Kim KH, Kang M, Song H, Oum C, Kim S, Lim Y, Ock CY, Yoon SO

Conference:

Location:

Type:

2023Journal

Lazertinib in pretreated EGFR T790M-mutated advanced non-small cell lung cancer: A real-world multicenter study

Kim H, Ahn BC, Lee J, Lee JB, Hong MH, Kim HR, Cho BC, Lim SM

Journal: Lung Cancer

Volume: 180, 107213

DOI:10.1016/j.lungcan.2023.107213

Medium Impact
2023Journal

Outcomes of an Acute Palliative Care Unit at a Comprehensive Cancer Center in Korea

Lee SW, Kwon JH, Beom SH, Shin SJ, Kim HS, Rha SY, Jung M, Sohn JH, Ahn JB, Chung HC, Kim GM, Kim HR, Kang BD, Hu YJ, Choi HJ

Journal: Journal of Palliative Medicine

Volume: 26(1), 9-16

DOI:10.1089/jpm.2022.0123

Medium Impact
2023Journal

Asian Subgroup Analysis of the Randomized Phase 3 CROWN Study of First-Line Lorlatinib Versus Crizotinib in Advanced ALK-Positive NSCLC

Zhou Q, Soo RA, Chang GC, Chiu CH, Hayashi H, Kim SW, Teraoka S, Goto Y, Zhou J, Ho-Fun Lee V, Kim DW, Han B, Ho JC, Lin CC, Lu S, Polli A, Calella AM, Martini JF, Wong CH, Mok T, Kim HR, Wu YL

Journal: JTO Clinical and Research Reports

Volume: 4(5), 100499

DOI:10.1016/j.jtocrr.2023.100499

High Impact
2023Journal

The Role of Adjuvant Therapy Following Surgical Resection of Small Cell Lung Cancer: A Multi-Center Study

Park SY, Park S, Lee GD, Kim HK, Choi S, Kim HR, Kim YH, Kim DK, Park SI, Hong TH, Choi YS, Kim J, Cho JH, Shim YM, Zo JI, Na KJ, Park IK, Kang CH, Kim YT, Park BJ, Lee CY, Lee JG, Kim DJ, Paik HC

Journal: Cancer Research and Treatment

Volume: 55(1), 94-102

Medium Impact
2023Journal

Comparison of Treatment Patterns and Clinical Outcomes by Gender in Locally Advanced Head and Neck Squamous Cell Carcinoma (KCSG HN13-01)

Lee YG, Kang EJ, Keam B, Choi JH, Kim JS, Park KU, Lee KE, Lee KW, Kim MK, Ahn HK, Shin SH, Kim HR, Kim SB, Kim HJ, Yun HJ

Journal: Cancers (Basel)

Volume: 15(2), 471

DOI:10.3390/cancers15020471

Medium Impact
2023Journal

A randomized Phase 2 study to compare erlotinib with or without bevacizumab in previously untreated patients with advanced non-small cell lung cancer with EGFR mutation

Lee Y, Kim HR, Hong MH, Lee KH, Park KU, Lee GK, Kim HY, Lee SH, Lim KY, Yoon SJ, Cho BC, Han JY

Journal: Cancer

Volume: 129(3), 405-414

DOI:10.1002/cncr.34567

High Impact
2023Journal

Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC

Kim HR, Awad MM, Navarro A, Gottfried M, Peters S, Csoszi T, Cheema PK, Rodriguez-Abreu D, Wollner M, Yang JC, Mazieres J, Orlandi FJ, Luft A, Gümüs M, Kato T, Kalemkerian GP, Luo Y, Santorelli ML, Pietanza MC, Rudin CM

Journal: JTO Clinical and Research Reports

Volume: 4(11), 100572

DOI:10.1016/j.jtocrr.2023.100572

High Impact

2022

17 publications
2022Journal

Treatment outcomes and radiotherapy deintensification strategies in human papillomavirus-associated tonsil cancer

Lee J, Kim K, Kim KH, Keum KC, Kim HR, Hong MH, Choi EC, Kim SH, Koh YW, Lee CG

Journal: Radiation Oncology

Volume: 17, 209

Medium Impact
2022Journal

Role of postoperative radiotherapy in resected adenoid cystic carcinoma of the head and neck

Choi SH, Yang AJ, Yoon SO, Kim HR, Hong MH, Kim SH, Choi EC, Keum KC, Lee CG

Journal: Radiation Oncology

Volume: 17, 197

Medium Impact
2022Journal

Treatment Patterns, Clinical Outcomes and Health Care Resource Utilisation in Patients with EGFR-mutated Metastatic Non-Small Cell Lung Cancer: A Real-World Study in South Korea

Molife C, Cho JM, Lapthorn J, Kang MJ, D’yachkova Y, Kim S, Colman S, Kim S, Szende A, Park JH, Ahn HK, Hong MH, Taipale KL, Kim HR

Journal: Drugs - Real World Outcomes

Volume: ,

Medium Impact
2022Journal

Efficacy and Safety of Brigatinib Compared With Crizotinib in Asian vs. Non-Asian Patients With Locally Advanced or Metastatic ALK-Inhibitor-Naive ALK+ Non-Small Cell Lung Cancer: Final Results From the Phase III ALTA-1L Study

Ahn MJ, Kim HR, Yang JCH, Han JY, Li JY, Hochmair MJ, Chang GC, Delmonte A, Lee KH, Campelo RG, Gridelli C, Spira AI, Califano R, Griesinger F, Ghosh S, Felip E, Kim DW, Liu Y, Zhang P, Popat S, Camidge DR

Journal: Clinical Lung Cancer

Volume: 23(8), 720-730

Medium Impact
2022Journal

Real World Characteristics and Clinical Outcomes of HER2-Mutant Non-Small Cell Lung Cancer Patients Detected by Next-Generation Sequencing

Ahn BC, Han YJ, Kim HR, Hong MH, Cho BC, Lim SM

Journal: Cancer Research and Treatment

Volume: ,

Medium Impact
2022Journal

Continuous centrifugal microfluidics (CCM) isolates heterogeneous circulating tumor cells via full automation

Woo HJ, Kim SH, Kang HJ, Lee SH, Lee SJ, Kim JM, Gurel O, Kim SY, Roh HR, Lee J, Park Y, Shin HY, Shin YI, Lee SM, Oh SY, Kim YZ, Chae JI, Lee S, Hong MH, Cho BC, Lee ES, Pantel K, Kim HR, Kim MS

Journal: Theranostics

Volume: 12(8), 3676-3689

Medium Impact
2022Journal

An Overview of Surgical Treatment of Thymic Epithelial Tumors in Korea: A Retrospective Multicenter Analysis

Lee JO, Lee GD, Kim HR, Kim DK, Park SI, Cho JH, Kim HK, Choi YS, Kim J, Shim YM, Park S, Park IK, Kang CH, Kim YT, Park SY, Lee CY, Lee JG, Kim DJ, Paik HC; Korean Association for Research on the Thymus

Journal: Journal of Chest Surgery

Volume: 55(2), 126-142

Low Impact
2022Journal

YH29407 with anti-PD-1 ameliorates anti-tumor effects via increased T cell functionality and antigen presenting machinery in the tumor microenvironment

Kim DK, Synn CB, Yang SM, Kang S, Baek S, Oh SW, Lee GJ, Kang HW, Lee YS, Park JS, Kim JH, Byeon Y, Kim YS, Lee DJ, Kim HW, Park JD, Lee SS, Lee JY, Lee JB, Kim CG, Hong MH, Lim SM, Kim HR, Pyo KH, Cho BC

Journal: Frontiers in Chemistry

Volume: 10, 998013

Medium Impact
2022Journal

The Development of AXL Inhibitors in Lung Cancer: Recent Progress and Challenges

Sang YB, Kim JH, Kim CG, Hong MH, Kim HR, Cho BC, Lim SM

Journal: Frontiers in Oncology

Volume: 12, 811247

Medium Impact
2022Journal

Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma

Doki Y, Ajani JA, Kato K, Xu J, Wyrwicz L, Motoyama S, Ogata T, Kawakami H, Hsu CH, Adenis A, El Hajbi F, Di Bartolomeo M, Braghiroli MI, Holtved E, Ostoich SA, Kim HR, Ueno M, Mansoor W, Yang WC, Liu T, Bridgewater J, Makino T, Xynos I, Liu X, Lei M, Kondo K, Patel A, Gricar J, Chau I, Kitagawa Y; CheckMate 648 Trial Investigators

Journal: The New England Journal of Medicine

Volume: 386(5), 449-462

High Impact
2022Journal

Lymphocyte dynamics during and after chemo-radiation correlate to dose and outcome in stage III NSCLC patients undergoing maintenance immunotherapy

Cho Y, Kim Y, Chamseddine I, Lee WH, Kim HR, Lee IJ, Hong MH, Cho BC, Lee CG, Cho S, Kim JS, Yoon HI, Grassberger C

Journal: Radiotherapy and Oncology

Volume: 168, 1-7

Medium Impact
2022Journal

A Phase 1/2 Study of Lazertinib 240 mg in Patients With Advanced EGFR T790M-Positive NSCLC After Previous EGFR Tyrosine Kinase Inhibitors

Cho BC, Han JY, Kim SW, Lee KH, Cho EK, Lee YG, Kim DW, Kim JH, Lee GW, Lee JS, Shim BY, Kim JS, Chun SH, Lee SS, Kim HR, Hong MH, Ahn JS, Sun JM, Lee Y, Lee DH, Kang JA, Lee N, Kwon MJ, Espenschied C, Yablonovitch A, Ahn MJ

Journal: Journal of Thoracic Oncology

Volume: 17(4), 558-567

High Impact
2022Journal

Predicting treatment outcomes using 18F-FDG PET biomarkers in patients with non-small-cell lung cancer receiving chemoimmunotherapy

Kim CG, Hwang SH, Kim KH, Yoon HI, Shim HS, Lee JH, Han Y, Ahn BC, Hong MH, Kim HR, Cho BC, Cho A, Lim SM

Journal: Therapeutic Advances in Medical Oncology

Volume: 14, 17588359211068732

Medium Impact
2022Journal

Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models

Lim SM, Yang SD, Lim S, Heo SG, Daniel S, Markovets A, Minoo R, Pyo KH, Yun MR, Hong MH, Kim HR, Cho BC

Journal: Therapeutic Advances in Medical Oncology

Volume: 14, 17588359221079125

Medium Impact
2022Journal

Disproportional enrichment of FoxP3+ CD4+ regulatory T cells shapes a suppressive tumour microenvironment in head and neck squamous cell carcinoma

Park S, Kim CG, Kim D, Hong MH, Choi EC, Kim SH, Park YM, Kim J, Yoon SO, Kim G, Shin S, Kim K, Koh YW, Ha SJ, Kim HR

Journal: Clinical and Translational Medicine

Volume: 12(3), e753

Medium Impact
2022Journal

Genomic Landscape of Non-Small Cell Lung Cancer (NSCLC) in East Asia Using Circulating Tumor DNA (ctDNA) in Clinical Practice

Cho BC, Loong HHF, Tsai CM, Teo MLP, Kim HR, Lim SM, Jain S, Olsen S, Park K

Journal: Current Oncology

Volume: 29(3), 2154-2164

Medium Impact
2022Journal

Plasma tumor mutation burden is associated with clinical benefit in patients with non-small cell lung cancer treated with anti-programmed death-1 monotherapy

Lee JB, Park HS, Choi SJ, Heo SG, An HJ, Kim HR, Hong MH, Lim SM, Chang K, Quinn K, Odegaard J, Shim BY, Cho BC

Journal: Therapeutic Advances in Medical Oncology

Volume: 14, 17588359221141761

Medium Impact

2021

26 publications
2021Journal

Analyses of CNS Response to Osimertinib in Patients with T790M-Positive Advanced NSCLC from ASTRIS Korean Subset, Open-Label Real-World Study

Ahn BC, Kim JH, Pyo KH, Lim SM, Hong MH, Kim HR, Cho BC

Journal: CANCERS

Volume: ,

Medium Impact
2021Journal

Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451

Owonikoko TK, Park K, Govindan R, Ready N, Reck M, Peters S, Dakhil SR, Navarro A, Rodríguez-Cid J, Schenker M, Lee JS, Gutierrez V, Percent I, Morgensztern D, Barrios CH, Greillier L, Baka S, Patel M, Lin WH, Selvaggi G, Baudelet C, Baden J, Pandya D, Doshi P, Kim HR

Journal: JOURNAL OF CLINICAL ONCOLOGY

Volume: ,

High Impact
2021Journal

Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma

Qian Li, Jingjing Han, Yonglin Yang, Yu Chen

Journal: JOURNAL OF HEPATOLOGY

Volume: ,

High Impact
2021Journal

Intracranial failure after hippocampal-avoidance prophylactic cranial irradiation in limited-stage small-cell lung cancer patients

Theresa A Cook, Matthew R Hoffmann, Amie J Ross, Kirsty J Turnbull, Justin Westhuyzen, Noel J Aherne

Journal: SCIENTIFIC REPORTS

Volume: ,

Medium Impact
2021Journal

Phase 2 study of TAS-117, an allosteric akt inhibitor in advanced solid tumors harboring phosphatidylinositol 3-kinase/v-akt murine thymoma viral oncogene homolog gene mutations

Lee JB, Jung M, Beom SH, Kim GM, Kim HR, Choi HJ, Sohn JH, Ahn JB, Rha SY, Chung HC

Journal: INVESTIGATIONAL NEW DRUGS

Volume: ,

Low Impact
2021Journal

Dynamic changes in circulating PD-1(+)CD8(+)T lymphocytes for predicting treatment response to PD-1 blockade in patients with non-small-cell lung cancer

Chang Gon Kim, Min Hee Hong, Kyung Hwan Kim, In-Ho Seo, Beung-Chul Ahn, Kyoung-Ho Pyo, Chun-Bong Synn, Hong In Yoon, Hyo Sup Shim, Yong Il Lee, Seong Jin Choi, Yun Jeong Lee, Ellen Janine Kim, Youngun Kim, Jeong-Eun Kwak, Jaehyung Jung, Su-Hyung Park, Soonmyung Paik, Eui-Cheol Shin, Hye Ryun Kim

Journal: EUROPEAN JOURNAL OF CANCER

Volume: ,

Medium Impact
2021Journal

Overexpression of poliovirus receptor is associated with poor prognosis in head and neck squamous cell carcinoma patients

Lim SM, Hong MH, Ha SJ, Hwang D, Chae S, Koh YW, Choi EC, Kim SH, Kim DH, Yoon SO, Kim HR

Journal: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Volume: ,

Low Impact
2021Journal

Clinical Insights Into Novel Immune Checkpoint Inhibitors

Lee JB, Ha SJ, Kim HR

Journal: FRONTIERS IN PHARMACOLOGY

Volume: ,

Medium Impact
2021Journal

Clinical Perspectives to Overcome Acquired Resistance to Anti-Programmed Death-1 and Anti-Programmed Death Ligand-1 Therapy in Non-Small Cell Lung Cancer

Lee YJ, Lee JB, Ha SJ, Kim HR

Journal: MOLECULES AND CELLS

Volume: ,

Medium Impact
2021Journal

Distinct Characteristics and Clinical Outcomes to Predict the Emergence of MET Amplification in Patients with Non-Small Cell Lung Cancer Who Developed Resistance after Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Ahn BC, Lee JH, Kim MH, Pyo KH, Lee CK, Lim SM, Kim HR, Cho BC, Hong MH

Journal: CANCERS

Volume: ,

Medium Impact
2021Journal

Outcomes and Biomarkers of Immune Checkpoint Inhibitor Therapy in Patients with Refractory Head and Neck Squamous Cell Carcinoma: KCSG HN18-12

Lee YG, Chang H, Keam B, Chun SH, Park J, Park KU, Shin SH, An HJ, Lee KE, Lee KW, Kim HR, Kim SB, Ahn MJ, Hwang IG

Journal: CANCER RESEARCH AND TREATMENT

Volume: ,

Medium Impact
2021Journal

A phase II study of poziotinib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

Lee JH, Heo SG, Ahn BC, Hong MH, Cho BC, Lim SM, Kim HR

Journal: CANCER MEDICINE

Volume: ,

Low Impact
2021Journal

Dysregulation of T FH-B-T RM lymphocyte cooperation is associated with unfavorable anti-PD-1 responses in EGFR-mutant lung cancer

Cho JW, Park S, Kim G, Han H, Shim HS, Shin S, Bae YS, Park SY, Ha SJ, Lee I, Kim HR

Journal: NATURE COMMUNICATIONS

Volume: ,

High Impact
2021Journal

Nivolumab with carboplatin, paclitaxel, and bevacizumab for first-line treatment of advanced nonsquamous non-small-cell lung cancer

Sugawara S, Lee JS, Kang JH, Kim HR, Inui N, Hida T, Lee KH, Yoshida T, Tanaka H, Yang CT, Nishio M, Ohe Y, Tamura T, Yamamoto N, Yu CJ, Akamatsu H, Namba Y, Sumiyoshi N, Nakagawa K

Journal: ANNALS OF ONCOLOGY

Volume: ,

High Impact
2021Journal

Human reference gut microbiome catalog including newly assembled genomes from under-represented Asian metagenomes

Kim CY, Lee M, Yang S, Kim K, Yong D, Kim HR, Lee I

Journal: GENOME MEDICINE

Volume: ,

High Impact
2021Journal

Genetic Analysis and Operative Outcomes in Patients with Oncogene-Driven Advanced NSCLC Treated with Cytoreductive Surgery as a Component of Local Consolidative Therapy

Park BJ, Shim HS, Lee CY, Lee JG, Kim HR, Lee SH, Hong MH, Park SY

Journal: CANCERS

Volume: ,

Medium Impact
2021Journal

A randomised phase 2b study comparing the efficacy and safety of belotecan vs. topotecan as monotherapy for sensitive-relapsed small-cell lung cancer

Jin-Hyoung Kang, Ki-Hyeong Lee, Dong-Wan Kim, Sang-We Kim, Hye Ryun Kim, Joo-Hang Kim, Jin-Hyuk Choi, Ho Jung An, Jin-Soo Kim, Joung-Soon Jang, Bong-Seog Kim, Heung Tae Kim

Journal: BRITISH JOURNAL OF CANCER

Volume: ,

Medium Impact
2021Journal

Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Advanced Oral Cavity Cancer in the Era of Modern Radiation Techniques

Tae Hyung Kim, In-Ho Cha, Eun Chang Choi, Hye Ryun Kim, Hyung Jun Kim, Se-Heon Kim, Ki Chang Keum, Chang Geol Lee

Journal: FRONTIERS IN ONCOLOGY

Volume: ,

Medium Impact
2021Journal

Clinical decision support algorithm based on machine learning to assess the clinical response to anti-programmed death-1 therapy in patients with non-small-cell lung cancer

Ahn BC, So JW, Synn CB, Kim TH, Kim JH, Byeon Y, Kim YS, Heo SG, Yang SD, Yun MR, Lim S, Choi SJ, Lee W, Kim DK, Lee EJ, Lee S, Lee DJ, Kim CG, Lim SM, Hong MH, Cho BC, Pyo KH, Kim HR

Journal: EUROPEAN JOURNAL OF CANCER

Volume: ,

Medium Impact
2021Journal

Overexpression of PVR and PD-L1 and its association with prognosis in surgically resected squamous cell lung carcinoma

Jii Bum Lee, Min Hee Hong, Seong Yong Park, Sehyun Chae, Daehee Hwang, Sang-Jun Ha, Hyo Sup Shim, Hye Ryun Kim

Journal: SCIENTIFIC REPORTS

Volume: ,

Medium Impact
2021Journal

Role and Function of O-GlcNAcylation in Cancer.

Lee JB, Pyo KH, Kim HR

Journal: Cancers (Basel)

Volume: ,

DOI:10.3390/cancers13215365

Medium Impact
2021Journal

Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancer.

Kim CG, Kim G, Kim KH, Park S, Shin S, Yeo D, Shim HS, Yoon HI, Park SY, Ha SJ, Kim HR

Journal: J Immunother Cancer

Volume: ,

DOI:10.1136/jitc-2021-002780

High Impact
2021Journal

Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma.

Jin N, Keam B, Cho J, Lee MJ, Kim HR, Torosyan H, Jura N, Ng PK, Mills GB, Li H, Zeng Y, Barbash Z, Tarcic G, Kang H, Bauman JE, Kim MO, VanLandingham NK, Swaney DL, Krogan NJ, Johnson DE, Grandis JR

Journal: J Clin Invest

Volume: ,

DOI:10.1172/JCI150335

High Impact
2021Journal

Therapeutic Singing as a Swallowing Intervention in Head and Neck Cancer Patients With Dysphagia.

Jo S, Yeo MS, Shin YK, Shin KH, Kim SH, Kim HR, Kim SJ, Cho SR

Journal: Integr Cancer Ther

Volume: ,

DOI:10.1177/15347354211065040

Low Impact
2021Journal

Brigatinib Versus Crizotinib in ALK Inhibitor-Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial.

Camidge DR, Kim HR, Ahn MJ, Yang JCH, Han JY, Hochmair MJ, Lee KH, Delmonte A, Garcia Campelo MR, Kim DW, Griesinger F, Felip E, Califano R, Spira AI, Gettinger SN, Tiseo M, Lin HM, Liu Y, Vranceanu F, Niu H, Zhang P, Popat S

Journal: J Thorac Oncol

Volume: ,

DOI:10.1016/j.jtho.2021.07.035

High Impact
2021Journal

Pan-Asian adaptation of the EHNS-ESMO-ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck.

Keam B, Machiels JP, Kim HR, Licitra L, Golusinski W, Gregoire V, Lee YG, Belka C, Guo Y, Rajappa SJ, Tahara M, Azrif M, Ang MK, Yang MH, Wang CH, Ng QS, Wan Zamaniah WI, Kiyota N, Babu S, Yang K, Curigliano G, Peters S, Kim TW, Yoshino T, Pentheroudakis G

Journal: ESMO Open

Volume: ,

DOI:10.1016/j.esmoop.2021.100309

Medium Impact

2020

21 publications
2020Journal

Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01)

Eun Joo Kang, Yun-Gyoo Lee, Bhumsuk Keam, Jin-Hyuk Choi, Jin-Soo Kim, Keon Uk Park, Kyoung Eun Lee, Hyo Jung Kim, Keun-Wook Lee, Min Kyoung Kim, Hee Kyung Ahn, Seong Hoon Shin, Jii Bum Lee, Jung Hye Kwon, Hye Ryun Kim, Sung-Bae Kim, Hwan Jung Yun

Journal: BMC CANCER

Volume: ,

Low Impact
2020Journal

Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR-MET Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion-Driven NSCLC

Jiyeon Yun, Soo-Hwan Lee, Seok-Young Kim, Seo-Yoon Jeong, Jae-Hwan Kim, Kyoung-Ho Pyo, Chae-Won Park, Seong Gu Heo, Mi Ran Yun, Sangbin Lim, Sun Min Lim, Min Hee Hong, Hye Ryun Kim, Meena Thayu, Joshua C Curtin, Roland E Knoblauch, Matthew V Lorenzi, Amy Roshak, Byoung Chul Cho

Journal: CANCER DISCOVERY

Volume: ,

High Impact
2020Journal

Comprehensive analyses of immunodynamics and immunoreactivity in response to treatment in ALK-positive non-small-cell lung cancer

Kyoung-Ho Pyo, Sun Min Lim, Chae-Won Park, Ha-Ni Jo, Jae Hwan Kim, Mi-Ran Yun, Dohee Kim, Chun-Feng Xin, Wongeun Lee, Bianca Gheorghiu, Min Hee Hong, Hye Ryun Kim, Hyo Sup Shim, Mi Jang, Sung Sook Lee, Byoung Chul Cho

Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER

Volume: ,

High Impact
2020Journal

Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study

Fumihiro Nishimura, Kentaro Oniki, Atsuhiro Yamashita, Keiichi Honda, Kenji Kawata, Tomoko Ushijima, Shinsuke Hamada, Shigeyuki Miyamura, Junji Saruwatari

Journal: JOURNAL OF CLINICAL ONCOLOGY

Volume: ,

High Impact
2020Journal

Prognostic Value of CD200R1 mRNA Expression in Head and Neck Squamous Cell Carcinoma

Hyun Chang, Yun-Gyoo Lee, Yoon Ho Ko, Jang Ho Cho, Jong-Kwon Choi, Keon Uk Park, Eun Joo Kang, Keun-Wook Lee, Sun Min Lim, Jin-Soo Kim, Hyun Woo Lee, Min Kyoung Kim, In Gyu Hwang, Sangwoo Kim, Byung-Ho Nam, Hye Ryun Kim

Journal: CANCERS

Volume: ,

Medium Impact
2020Journal

Combination of PD-L1 and PVR determines sensitivity to PD-1 blockade

Bo Ryeong Lee, Sehyun Chae, Jihyun Moon, Myeong Joon Kim, Hankyu Lee, Hyuk Wan Ko, Byoung Chul Cho, Hyo Sup Shim, Daehee Hwang, Hye Ryun Kim, Sang-Jun Ha

Journal: JCI INSIGHT

Volume: ,

Medium Impact
2020Journal

Repotrectinib Exhibits Potent Antitumor Activity in Treatment-Naïve and Solvent-Front-Mutant ROS1-Rearranged Non-Small Cell Lung Cancer

Mi Ran Yun, Dong Hwi Kim, Seok-Young Kim, Hyeong-Seok Joo, You Won Lee, Hun Mi Choi, Chae Won Park, Seong Gu Heo, Han Na Kang, Sung Sook Lee, Adam J Schoenfeld, Alexander Drilon, Seok-Gu Kang, Hyo Sup Shim, Min Hee Hong, J Jean Cui, Hye Ryun Kim, Byoung Chul Cho

Journal: CLINICAL CANCER RESEARCH

Volume: ,

High Impact
2020Journal

Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18-12

Yiyue Huang, Yuexiang Su, Yuanyuan Chen, Jingxuan Xu, Lu Zhu, Haowen Wei, Shuiling Qin, Yuchong Peng, Lunan Qi

Journal: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Volume: ,

Low Impact
2020Journal

The Interplay between Slow-Cycling, Chemoresistant Cancer Cells and Fibroblasts Creates a Proinflammatory Niche for Tumor Progression

Jaebeom Cho, Hyo-Jong Lee, Su Jung Hwang, Hye-Young Min, Han Na Kang, A-Young Park, Seung Yeob Hyun, Jeong Yeon Sim, Ho Jin Lee, Hyun-Ji Jang, Young-Ah Suh, Sungyoul Hong, Young Kee Shin, Hye Ryun Kim, Ho-Young Lee

Journal: CANCER RESEARCH

Volume: ,

High Impact
2020Journal

Peripheral natural killer cells and myeloid-derived suppressor cells correlate with anti-PD-1 responses in non-small cell lung cancer

Je-In Youn, Su-Myeong Park, Seyeon Park, Gamin Kim, Hee-Jae Lee, Jimin Son, Min Hee Hong, Aziz Ghaderpour, Bumseo Baik, Jahirul Islam, Ji-Woong Choi, Eun-Young Lee, Hang-Rae Kim, Sang-Uk Seo, Soonmyung Paik, Hong In Yoon, Inkyung Jung, Chun-Feng Xin, Hyun-Tak Jin, Byoung Chul Cho, Seung-Yong Seong, Sang-Jun Ha, Hye Ryun Kim

Journal: SCIENTIFIC REPORTS

Volume: ,

Medium Impact
2020Journal

Molecular subtypes of oropharyngeal cancer show distinct immune microenvironment related with immune checkpoint blockade response

Min Hwan Kim, Jae-Hwan Kim, Ji Min Lee, Jae Woo Choi, Dongmin Jung, Hojin Cho, Hyundeok Kang, Min Hee Hong, Su Jin Heo, Se Heon Kim, Eun Chang Choi, Da Hee Kim, Young Min Park, Sangwoo Kim, Sun Och Yoon, Yoon Woo Koh, Byoung Chul Cho, Hye Ryun Kim

Journal: BRITISH JOURNAL OF CANCER

Volume: ,

Medium Impact
2020Journal

Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer

Han Na Kang, Jae-Hwan Kim, A-Young Park, Jae Woo Choi, Sun Min Lim, Jinna Kim, Eun Joo Shin, Min Hee Hong, Kyoung-Ho Pyo, Mi Ran Yun, Dong Hwi Kim, Hanna Lee, Sun Och Yoon, Da Hee Kim, Young Min Park, Hyung Kwon Byeon, Inkyung Jung, Soonmyung Paik, Yoon Woo Koh, Byoung Chul Cho, Hye Ryun Kim

Journal: BMC CANCER

Volume: ,

Low Impact
2020Journal

Immunotherapy for Non-small Cell Lung Cancer: Current Landscape and Future Perspectives

Diamone Gathers, Cameron Oswalt, Laura Alder, Kevin Chen, Jordyn P Higgins, Jeffrey M Clarke, Eziafa I Oduah

Journal: IMMUNE NETWORK

Volume: ,

Medium Impact
2020Journal

Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer

Kim K, Park S, Park SY, Kim G, Park SM, Cho JW, Kim DH, Park YM, Koh YW, Kim HR, Ha SJ

Journal: GENOME MEDICINE

Volume: ,

High Impact
2020Journal

The feasibility and safety of radical esophagectomy in patients receiving neoadjuvant chemoradiotherapy with pembrolizumab for esophageal squamous cell carcinoma

Seong Yong Park, Min Hee Hong, Hye Ryun Kim, Chang Geol Lee, Jae Ho Cho, Byoung Chul Cho, Dae Joon Kim

Journal: JOURNAL OF THORACIC DISEASE

Volume: ,

Low Impact
2020Journal

MAML1/2 promote YAP/TAZ nuclear localization and tumorigenesis

Jiyoung Kim, Hyeryun Kwon, You Keun Shin, Gahyeon Song, Taebok Lee, Youngeun Kim, Wonyoung Jeong, Ukjin Lee, Xianglan Zhang, Gilyeong Nam, Hei-Cheul Jeung, Wantae Kim, Eek-Hoon Jho

Journal: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Volume: ,

High Impact
2020Journal

Mouse-human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neck

Hye Ryun Kim, Han Na Kang, Mi Ran Yun, Kwon Young Ju, Jae Woo Choi, Dong Min Jung, Kyoung Ho Pyo, Min Hee Hong, Myoung-Ju Ahn, Jong-Mu Sun, Han Sang Kim, Jinna Kim, Jinseon Yoo, Kyu Ryung Kim, Yoon Woo Koh, Se Heon Kim, Eun Chang Choi, Sun Ock Yoon, Hyo Sup Shim, Soonmyung Paik, Tae-Min Kim, Byoung Chul Cho

Journal: BRITISH JOURNAL OF CANCER

Volume: ,

Medium Impact
2020Journal

Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial

D Ross Camidge, Hye Ryun Kim, Myung-Ju Ahn, James C H Yang, Ji-Youn Han, Maximilian J Hochmair, Ki Hyeong Lee, Angelo Delmonte, Maria Rosario García Campelo, Dong-Wan Kim, Frank Griesinger, Enriqueta Felip, Raffaele Califano, Alexander Spira, Scott N Gettinger, Marcello Tiseo, Huamao M Lin, Neeraj Gupta, Michael J Hanley, Quanhong Ni, Pingkuan Zhang, Sanjay Popat

Journal: JOURNAL OF CLINICAL ONCOLOGY

Volume: ,

High Impact
2020Journal

Tumor-Infiltrating Regulatory T-cell Accumulation in the Tumor Microenvironment Is Mediated by IL33/ST2 Signaling

Jimin Son, Jae-Won Cho, Hyo Jin Park, Jihyun Moon, Seyeon Park, Hoyoung Lee, Jeewon Lee, Gamin Kim, Su-Myeong Park, Sergio A Lira, Andrew N Mckenzie, Hye Young Kim, Cheol Yong Choi, Yong Taik Lim, Seong Yong Park, Hye Ryun Kim, Su-Hyung Park, Eui-Cheol Shin, Insuk Lee, Sang-Jun Ha

Journal: CANCER IMMUNOLOGY RESEARCH

Volume: ,

High Impact
2020Journal

Phase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinoma

Fei Yan, Jingni Zhu, Qibing Wu, Yuanyuan Ren, Xinnian Yu, Zijian Sun, Yang Liu, Changjiang Sun, Yan Sun

Journal: CANCER

Volume: ,

High Impact
2020Journal

Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer

Jae-Won Cho, Min Hee Hong, Sang-Jun Ha, Young-Joon Kim, Byoung Chul Cho, Insuk Lee, Hye Ryun Kim

Journal: EXPERIMENTAL AND MOLECULAR MEDICINE

Volume: ,

High Impact

2019

21 publications
2019Journal

A Randomized, Open-Label, Phase II Study Comparing Pemetrexed Plus Cisplatin Followed by Maintenance Pemetrexed versus Pemetrexed Alone in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer after Failure of First-Line EGFR Tyrosine Kinase Inhibitor: KCSG-LU12-13

Kwai Han Yoo, Su Jin Lee, Jinhyun Cho, Ki Hyeong Lee, Keon Uk Park, Ki Hwan Kim, Eun Kyung Cho, Yoon Hee Choi, Hye Ryun Kim, Hoon-Gu Kim, Heui June Ahn, Ha Yeon Lee, Hwan Jung Yun, Jin-Hyoung Kang, Jaeheon Jeong, Moon Young Choi, Sin-Ho Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn

Journal: CANCER RESEARCH AND TREATMENT

Volume: ,

Medium Impact
2019Journal

Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1-2 study

Myung-Ju Ahn, Ji-Youn Han, Ki Hyeong Lee, Sang-We Kim, Dong-Wan Kim, Yun-Gyoo Lee, Eun Kyung Cho, Joo-Hang Kim, Gyeong-Won Lee, Jong-Seok Lee, Young Joo Min, Jin-Soo Kim, Sung Sook Lee, Hye Ryun Kim, Min Hee Hong, Jin Seok Ahn, Jong-Mu Sun, Heung Tae Kim, Dae Ho Lee, Sohee Kim, Byoung Chul Cho

Journal: LANCET ONCOLOGY

Volume: ,

High Impact
2019Journal

Molecular characterization of lung adenocarcinoma from Korean patients using next generation sequencing

You Jin Chun, Jae Woo Choi, Min Hee Hong, Dongmin Jung, Hyeonju Son, Eun Kyung Cho, Young Joo Min, Sang-We Kim, Keunchil Park, Sung Sook Lee, Sangwoo Kim, Hye Ryun Kim, Byoung Chul Cho

Journal: PLOS ONE

Volume: ,

Low Impact
2019Journal

Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung Adenocarcinoma

Seok-Young Kim, Ji Yeon Lee, Dong Hwi Kim, Hyeong -Seok Joo, Mi Ran Yun, Dongmin Jung, Jiyeon Yun, Seong Gu Heo, Beung -Chul Ahn, Chae Won Park, Kyoung Ho Pyo, You Jin Chun, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho

Journal: SCIENTIFIC REPORTS

Volume: ,

Medium Impact
2019Journal

High CD3 and ICOS and low TIM-3 expression predict favourable survival in resected oesophageal squamous cell carcinoma

Min Hee Hong, Su-Jin Shin, Sung Kwan Shin, Dae Joon Kim, Jae Ill Zo, Young Mog Shim, Seung Eun Lee, Byoung Chul Cho, Seong Yong Park, Yoon-La Choi, Hye Ryun Kim

Journal: SCIENTIFIC REPORTS

Volume: ,

Medium Impact
2019Journal

Impact of Treatment-Related Lymphopenia on Immunotherapy for Advanced Non-Small Cell Lung Cancer

Ye Zhang, Cheng Huang, Shanqing Li

Journal: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Volume: ,

Medium Impact
2019Journal

LBA1_PR - Nivolumab (nivo) plus ipilimumab (ipi), nivo, or placebo (pbo) as maintenance therapy in patients (pts) with extensive disease small cell lung cancer (ED-SCLC) after first-line (1L) platinum-based chemotherapy (chemo): Results from the double-blind, randomized phase III CheckMate 451 study

Owonikoko TK, Kim HR, Govindan R, Ready N, Reck M, Peters S, Dakhil SR, Navarro A, Rodriguez-Cid J, Schenker M, Lee JS

Journal: ANNALS OF ONCOLOGY

Volume: ,

High Impact
2019Journal

Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function

Hye Ryun Kim, Hyo Jin Park, Jimin Son, Jin Gu Lee, Kyung Young Chung, Nam Hoon Cho, Hyo Sup Shim, Seyeon Park, Gamin Kim, Hong In Yoon, Hyun Gyung Kim, Yong Woo Jung, Byoung Chul Cho, Seong Yong Park, Sun Young Rha, Sang-Jun Ha

Journal: JOURNAL FOR IMMUNOTHERAPY OF CANCER

Volume: ,

High Impact
2019Journal

Dynamic changes in PD-L1 expression and CD8+ T cell infiltration in non-small cell lung cancer following chemoradiation therapy

Eun-Ah Choe, Yoon Jin Cha, Jae-Hwan Kim, Kyoung Ho Pyo, Min Hee Hong, Seong Yong Park, Hyo Sup Shim, Inkyung Jung, Chang Young Lee, Byoung Chul Cho, Hye Ryun Kim

Journal: LUNG CANCER

Volume: ,

Medium Impact
2019Journal

Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer

Qingwang Hua, Zhenyun Ye, Suyue Liu

Journal: Annals of Oncology

Volume: ,

High Impact
2019Journal

Predictive factors for the development of diabetes in cancer patients treated with phosphatidylinositol 3-kinase inhibitors

Gyuri Kim, Myungeun Yoo, Min Hee Hong, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Hye Ryun Kim, Yong-Ho Lee, Byoung Chul Cho

Journal: Cancer Chemotherapy and Pharmacology

Volume: ,

Low Impact
2019Journal

A phase Ib study of the combination of afatinib and ruxolitinib in EGFR mutant NSCLC with progression on EGFR-TKIs

Ji Soo Park, Min Hee Hong, You Jin Chun, Hye Ryun Kim, Byoung Chul Cho

Journal: Lung Cancer

Volume: ,

Medium Impact
2019Journal

Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma

Sun Min Lim, Sang Hee Cho, In Gyu Hwang, Jae Woo Choi, Hyun Chang, Myung-Ju Ahn, Keon Uk Park, Ji-Won Kim, Yoon Ho Ko, Hee Kyung Ahn, Byoung Chul Cho, Byung-Ho Nam, Sang Hoon Chun, Ji Hyung Hong, Jung Hye Kwon, Jong Gwon Choi, Eun Joo Kang, Tak Yun, Keun-Wook Lee, Joo-Hang Kim, Jin Soo Kim, Hyun Woo Lee, Min Kyoung Kim, Dongmin Jung, Ji Eun Kim, Bhumsuk Keam, Hwan Jung Yun, Sangwoo Kim, Hye Ryun Kim

Journal: Cancer Research and Treatment

Volume: ,

Medium Impact
2019Journal

Comprehensive analysis of the characteristics and treatment outcomes of patients with non-small cell lung cancer treated with anti-PD-1 therapy in real-world practice

Beung-Chul Ahn, Kyoung-Ho Pyo, Chun-Feng Xin, Dongmin Jung, Hyo Sup Shim, Chang Young Lee, Seong Yong Park, Hong In Yoon, Min Hee Hong, Byoung Chul Cho, Hye Ryun Kim

Journal: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Volume: ,

Low Impact
2019Journal

YH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non-Small Cell Lung Cancer

Jiyeon Yun, Min Hee Hong, Seok-Young Kim, Chae-Won Park, Soyoung Kim, Mi Ran Yun, Han Na Kang, Kyoung-Ho Pyo, Sung Sook Lee, Jong Sung Koh, Ho-Juhn Song, Dong Kyun Kim, Young-Sung Lee, Se-Woong Oh, Soongyu Choi, Hye Ryun Kim, Byoung Chul Cho

Journal: CLINICAL CANCER RESEARCH

Volume: ,

High Impact
2019Journal

TRIUMPH Trial: One Small Step Could Become One Giant Leap for Precision Oncology in Head and Neck Cancer

Bhumsuk Keam, Hye Ryun Kim, Hwan Jung Yun

Journal: CANCER RESEARCH AND TREATMENT

Volume: ,

Medium Impact
2019Journal

Indoor radon exposure increases tumor mutation burden in never-smoker patients with lung adenocarcinoma

Sun Min Lim, Jae Woo Choi, Min Hee Hong, Dongmin Jung, Chang Young Lee, Seong Yong Park, Hyo Sup Shim, Seungsoo Sheen, Kyeong Im Kwak, Dae Ryong Kang, Byoung Chul Cho, Hye Ryun Kim

Journal: LUNG CANCER

Volume: ,

Medium Impact
2019Journal

Neoadjuvant therapy for thymic neoplasms reduces tumor volume per 3D-reconstructed images but does not improve the complete resection rate

Suh JW, Park SY, Lee CY, Song SH, Kim DJ, Paik HC, Chung KY, Hong MH, Kim HR, Cho BC, Lee JG

Journal: PLOS ONE

Volume: ,

Low Impact
2019Journal

The Ratio of Peripheral Regulatory T Cells to Lox-1+ Polymorphonuclear Myeloid-derived Suppressor Cells Predicts the Early Response to Anti-PD-1 Therapy in Patients with Non-Small Cell Lung Cancer

Hye Ryun Kim, Su-Myeong Park, Sang-Uk Seo, Inkyung Jung, Hong In Yoon, Dmitry I Gabrilovich, Byoung Chul Cho, Seung-Yong Seong, Sang-Jun Ha, Je-In Youn

Journal: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Volume: ,

High Impact
2019Journal

Real-World Analysis of the Efficacy of Rebiopsy and EGFR Mutation Test of Tissue and Plasma Samples in Drug-Resistant Non-Small Cell Lung Cancer

Min Hee Hong, Hye Ryun Kim, Beung Chul Ahn, Su Jin Heo, Jee Hung Kim, Byoung Chul Cho

Journal: YONSEI MEDICAL JOURNAL

Volume: ,

Low Impact
2019Journal

Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK-rearranged lung cancer

Mi Ran Yun, Hun Mi Choi, You Won Lee, Hyeong Seok Joo, Chae Won Park, Jae Woo Choi, Dong Hwi Kim, Han Na Kang, Kyoung-Ho Pyo, Eun Joo Shin, Hyo Sup Shim, Ross A Soo, James Chih-Hsin Yang, Sung Sook Lee, Hyun Chang, Min Hwan Kim, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho

Journal: EMBO MOLECULAR MEDICINE

Volume: ,

High Impact

2018

11 publications
2018Journal

Characteristics and Outcome of ROS1-Positive Non-Small Cell Lung Cancer Patients in Routine Clinical Practice

Sehhoon Park, Beung-Chul Ahn, Sung Won Lim, Jong-Mu Sun, Hye Ryun Kim, Min Hee Hong, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Yoon La Choi, Byoung Chul Cho, Myung-Ju Ahn

Journal: JOURNAL OF THORACIC ONCOLOGY

Volume: ,

High Impact
2018Journal

A Clinical Trial of Combination Neoadjuvant Chemotherapy and Transoral Robotic Surgery in Patients with T3 and T4 Laryngo-Hypopharyngeal Cancer

Young Min Park, Ki Chang Keum, Hye Ryun Kim, Byoung Chul Cho, Da Hee Kim, Nam Hoon Cho, Se-Heon Kim

Journal: ANNALS OF SURGICAL ONCOLOGY

Volume: ,

Medium Impact
2018Journal

The Benefit of Pro Re Nata Antiemetics Provided With Guideline-Consistent Antiemetics in Delayed Nausea Control

Sun Young Rha, Joohyuk Sohn, Gun Min Kim, Hye Ryun Kim, Jiyeon Lee

Journal: CANCER NURSING

Volume: ,

Low Impact
2018Journal

Efficacy and safety of vinorelbine plus cisplatin chemotherapy for patients with recurrent and/or metastatic salivary gland cancer of the head and neck

Marta Rogalska, Pawel Scierski, Marta Gamrot-Wrzol, Maciej Misiolek, Wojciech Scierski

Journal: HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Volume: ,

Low Impact
2018Journal

Brigatinib versus Crizotinib in ALK-Positive Non–Small-Cell Lung Cancer

Vera Damuzzo, Lorenzo Gasperoni, Luna Del Bono, Andrea Ossato, Alessandro Inno, Andrea Messori

Journal: New England Journal of Medicine

Volume: ,

High Impact
2018Journal

ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinoma

M R Yun, H M Choi, H N Kang, Yw Lee, H-S Joo, D H Kim, H R Kim, M H Hong, S O Yoon, B C Cho

Journal: ONCOGENE

Volume: ,

Medium Impact
2018Journal

Survival and Functional Outcome after Treatment for Primary Base of Tongue Cancer: A Comparison of Definitive Chemoradiotherapy versus Surgery Followed by Adjuvant Radiotherapy.

Sangjoon Park, Yeona Cho, Jeongshim Lee, Yoon Woo Koh, Se-Heon Kim, Eun Chang Choi, Hye Ryun Kim, Ki Chang Keum, Kyung Ran Park, Chang Geol Lee

Journal: CANCER RESEARCH AND TREATMENT

Volume: ,

Medium Impact
2018Journal

Enhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK Inhibitors.

Mi Ran Yun, Sun Min Lim, Seon-Kyu Kim, Hun Mi Choi, Kyoung-Ho Pyo, Seong Keun Kim, Ji Min Lee, You Won Lee, Jae Woo Choi, Hye Ryun Kim, Min Hee Hong, Keeok Haam, Nanhyung Huh, Jong-Hwan Kim, Yong Sung Kim, Hyo Sup Shim, Ross Andrew Soo, Jin-Yuan Shih, James Chih-Hsin Yang, Mirang Kim, Byoung Chul Cho

Journal: CANCER RESEARCH

Volume: ,

High Impact
2018Journal

Effects of Serum Albumin, Calcium Levels, Cancer Stage and Performance Status on Weight Loss in Parathyroid Hormone-Related Peptide Positive or Negative Patients with Cancer

Walker Lyons, E McAuley Fish, Richard J Bleicher, Cecilia Chang, Allison A Aggon, Alycia L So, Andrea S Porpiglia, Austin D Williams

Journal: Endocrinology and Metabolism (대한내분비학회지)

Volume: ,

Low Impact
2018Journal

Establishment of a platform of non-small-cell lung cancer patient-derived xenografts with clinical and genomic annotation

Josiah Voth Park, Raghav Chandra, Ling Cai, Debolina Ganguly, Huiyu Li, Jason E Toombs, Luc Girard, Rolf A Brekken, John D Minna

Journal: LUNG CANCER

Volume: ,

Medium Impact
2018Journal

Radon Exposure-induced Genetic Variations in Lung Cancers among Never Smokers

Jung Ran Choi, Sang Baek Koh, Hye Ryun Kim, Hyojin Lee, Dae Ryong Kang

Journal: JOURNAL OF KOREAN MEDICAL SCIENCE

Volume: ,

Low Impact

2017

19 publications
2017Journal

Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement.

Sun Min Lim, Hye Ryun Kim, Jong-Seok Lee, Ki Hyeong Lee, Yun-Gyoo Lee, Young Joo Min, Eun Kyung Cho, Sung Sook Lee, Bong-Seog Kim, Moon Young Choi, Hyo Sup Shim, Jin-Haeng Chung, Yoon La Choi, Min Jeong Lee, Maria Kim, Joo-Hang Kim, Siraj M Ali, Myung-Ju Ahn, Byoung Chul Cho

Journal: JOURNAL OF CLINICAL ONCOLOGY

Volume: ,

High Impact
2017Journal

Detection of activating and acquired resistant mutation in plasma from EGFR-mutated NSCLC patients by peptide nucleic acid (PNA) clamping-assisted fluorescence melting curve analysis

Chang Gon Kim, Hyo Sup Shim, Min Hee Hong, Yoon Jin Cha, Su Jin Heo, Hyung Soon Park, Jee Hung Kim, Jin Gu Lee, Chang Young Lee, Byoung Chul Cho, Hye Ryun Kim

Journal: ONCOTARGET

Volume: ,

Low Impact
2017Journal

Prevalence and prognostic implications of psychological distress in patients with gastric cancer

Gun Min Kim, Seung Jun Kim, Su Kyung Song, Hye Ryun Kim, Beo Deul Kang, Sung Hoon Noh, Hyun Cheol Chung, Kyung Ran Kim, Sun Young Rha

Journal: BMC CANCER

Volume: ,

Low Impact
2017Journal

Patient Experience of Symptoms and Side Effects when Treated with Osimertinib for Advanced Non-Small-Cell Lung Cancer: A Qualitative Interview Substudy

Rydén A, Blackhall F, Kim HR, Pillai RN, Braam L, Martin ML, Walding A

Journal: PATIENT-PATIENT CENTERED OUTCOMES RESEARCH

Volume: ,

Low Impact
2017Journal

Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer

Mok TS, Wu Y-L, Ahn M-J, Garassino MC, Kim HR, Ramalingam SS, Shepherd FA, He Y, Akamatsu H, Theelen WS, Lee CK, Sebastian M, Templeton A, Mann H, Marotti M, Ghiorghiu S, Papadimitrakopoulou VA; AURA3 Investigators

Journal: NEW ENGLAND JOURNAL OF MEDICINE

Volume: ,

High Impact
2017Journal

A randomized; phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01) (vol 8; pg 15943; 2017)

Kim HR, Jang JS, Sun JM, Ahn MJ, Kim DW, Jung I, Lee KH, Kim JH, Lee DH, Kim SW, Cho BC

Journal: ONCOTARGET

Volume: ,

Low Impact
2017Journal

Architectural patterns of p16 immunohistochemical expression associated with cancer immunity and prognosis of head and neck squamous cell carcinoma

Hyang Joo Ryu, Eun Kyung Kim, Su Jin Heo, Byoung Chul Cho, Hye Ryun Kim, Sun Och Yoon

Journal: APMIS

Volume: ,

Low Impact
2017Journal

Next-generation sequencing reveals novel resistance mechanisms and molecular heterogeneity in EGFR-mutant non-small cell lung cancer with acquired resistance to EGFR-TKIs

Choong-Kun Lee, Sora Kim, Jae Seok Lee, Jeong Eun Lee, Sung-Moo Kim, In Seok Yang, Hye Ryun Kim, Jeong Ho Lee, Sangwoo Kim, Byoung Chul Cho

Journal: LUNG CANCER

Volume: ,

Medium Impact
2017Journal

Validation of ALK/ROS1 Dual Break Apart FISH Probe probe in non-small-cell lung cancer

Federica Zito Marino, Giulio Rossi, Immacolata Cozzolino, Marco Montella, Mariacarolina Micheli, Giuseppe Bogina, Enrico Munari, Matteo Brunelli, Renato Franco

Journal: LUNG CANCER

Volume: ,

Medium Impact
2017Journal

Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study

Ahn MJ, Kim DW, Cho BC, Kim SW, Lee JS, Ahn JS, Kim TM, Lin CC, Kim HR, John T, Kao S, Goldman JW, Su WC, Natale R, Rabbie S, Harrop B, Overend P, Yang Z, Yang JC

Journal: LANCET RESPIRATORY MEDICINE

Volume: ,

High Impact
2017Journal

Transoral robotic surgery-based therapy in patients with stage III-IV oropharyngeal squamous cell carcinoma

Young Min Park, Hye Ryun Kim, Byoung Chul Cho, Ki Chang Keum, Nam Hoon Cho, Se-Heon Kim

Journal: ORAL ONCOLOGY

Volume: ,

Medium Impact
2017Journal

Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01)

Kristina Lindemann, Dominique Berton, Jalid Sehouli, René DePont Christensen, Sevilay Altintas, Anja Ør Knudsen, Pierre-Etienne Heudel, Beyhan Ataseven, Ignace Vergote, Gabriel Lindahl, Coriolan Lebreton, Fabienne Schochter, Annika Auranen, Philippe Follana, Kristine Madsen, Frédéric Selle, Karen Stampe Petersson, Florence Joly, Elena Ioana Braicu, Mansoor Raza Mirza

Journal: CANCER

Volume: ,

High Impact
2017Journal

Significance of immune checkpoint proteins in EGFR-mutant non-small cell lung cancer

Zhidong Yin, Bohao Sun, Lu Cheng, Xi Xu, Sisi Wang, Shumei Wei, Er Jin

Journal: LUNG CANCER

Volume: ,

Medium Impact
2017Journal

Predictive factors of early distant brain failure after gamma knife radiosurgery alone in patients with brain metastases of non-small-cell lung cancer

Robert H Press, Danielle M Boselli, James T Symanowski, Scott P Lankford, Robert J McCammon, Benjamin J Moeller, John H Heinzerling, Carolina E Fasola, Stuart H Burri, Kirtesh R Patel, Anthony L Asher, Ashley L Sumrall, Walter J Curran, Hui-Kuo G Shu, Ian R Crocker, Roshan S Prabhu

Journal: JOURNAL OF NEURO-ONCOLOGY

Volume: ,

Low Impact
2017Journal

Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma

H R Kim, H N Kang, H S Shim, E Y Kim, J Kim, D J Kim, J G Lee, C Y Lee, M H Hong, S-M Kim, H Kim, K-H Pyo, M R Yun, H J Park, J Y Han, H A Youn, M-J Ahn, S Paik, T-M Kim, B C Cho

Journal: ANNALS OF ONCOLOGY

Volume: ,

High Impact
2017Journal

Optimal dose and volume for postoperative radiotherapy in brain oligometastases from lung cancer: a retrospective study

Seung Yeun Chung, Jong Hee Chang, Hye Ryun Kim, Byoung Chul Cho, Chang Geol Lee, Chang-Ok Suh

Journal: RADIATION ONCOLOGY JOURNAL

Volume: ,

Low Impact
2017Journal

Establishment of a Conditional Transgenic Mouse Model Recapitulating EML4-ALK-Positive Human Non-Small Cell Lung Cancer

Kyoung Ho Pyo, Sun Min Lim, Hye Ryun Kim, Young Hoon Sung, Mi Ran Yun, Sung-Moo Kim, Hwan Kim, Han Na Kang, Ji Min Lee, Sang Gyun Kim, Chae Won Park, Hyun Chang, Hyo Sup Shim, Han-Woong Lee, Byoung Chul Cho

Journal: JOURNAL OF THORACIC ONCOLOGY

Volume: ,

High Impact
2017Journal

Novel Genetic Associations Between Lung Cancer and Indoor Radon Exposure

Jung Ran Choi, Sang-Baek Koh, Seong Yong Park, Hye Ryun Kim, Hyojin Lee, Dae Ryong Kang

Journal: JOURNAL OF CANCER PREVENTION

Volume: ,

Low Impact
2017Journal

Concordance of programmed death-ligand 1 expression between primary and metastatic non-small cell lung cancer by immunohistochemistry and RNA in situ hybridization

Hye Ryun Kim, Yoon Jin Cha, Min Hee Hong, Manoj Gandhi, Shauna Levinson, Inkyung Jung, Jin Gu Lee, Chang Young Lee, Byoung Chul Cho, Sang-Jun Ha, Hyo Sup Shim

Journal: ONCOTARGET

Volume: ,

Low Impact

2016

22 publications
2016Journal

A Case of ALK-Rearranged Adenocarcinoma with Small Cell Carcinoma-Like Transformation and Resistance to Crizotinib

Yoon Jin Cha, Byoung Chul Cho, Hye Ryun Kim, Hye-Jeong Lee, Hyo Sup Shim

Journal: JOURNAL OF THORACIC ONCOLOGY

Volume: ,

High Impact
2016Journal

Exome sequencing reveals recurrent REV3L mutations in cisplatin-resistant squamous cell carcinoma of head and neck

Kie Kyon Huang, Kang Won Jang, Sangwoo Kim, Han Sang Kim, Sung-Moo Kim, Hyeong Ju Kwon, Hye Ryun Kim, Hwan Jung Yun, Myung Ju Ahn, Keon Uk Park, Kalpana Ramnarayanan, John R McPherson, Shenli Zhang, Je-Keun Rhee, André L Vettore, Kakoli Das, Takatsugu Ishimoto, Joo Hang Kim, Yoon Woo Koh, Se Hun Kim, Eun Chang Choi, Bin Tean Teh, Steven G Rozen, Tae-Min Kim, Patrick Tan, Byoung Chul Cho

Journal: SCIENTIFIC REPORTS

Volume: ,

Medium Impact
2016Journal

Hippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases From Lung Adenocarcinoma: Early Response and Dosimetric Evaluation.

Kyung Hwan Kim, Byoung Chul Cho, Chang Geol Lee, Hye Ryun Kim, Yang Gun Suh, Jun Won Kim, Chihwan Choi, Jong Geal Baek, Jaeho Cho

Journal: TECHNOLOGY IN CANCER RESEARCH & TREATMENT

Volume: ,

Low Impact
2016Journal

Serum PTHrP Predicts Weight Loss in Cancer Patients Independent of Hypercalcemia, Inflammation, and Tumor Burden

Namki Hong, Hye-Jin Yoon, Yong-Ho Lee, Hye Ryun Kim, Byung Wan Lee, Yumie Rhee, Eun Seok Kang, Bong-Soo Cha, Hyun Chul Lee

Journal: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Volume: ,

Medium Impact
2016Journal

Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy

Hyung Soon Park, Sun Min Lim, Ho Jung Shin, Arthur Cho, Jae-Gook Shin, Min Goo Lee, Hye Ryun Kim, Joo Hang Kim, Byoung Chul Cho

Journal: PHARMACOGENETICS AND GENOMICS

Volume: ,

Low Impact
2016Journal

PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients

Ximo Xu, Jingyi Liu, Wei Qin, Chengsheng Ding, Zhenghao Cai, Duohuo Shu, Hao Zhong, Yanyan Hu, Mengqin Yu, Leqi Zhou, Jianwen Li, Minhua Zheng, Bin Li, Sen Zhang, Xiao Yang, Bo Feng

Journal: SCIENTIFIC REPORTS

Volume: ,

Medium Impact
2016Journal

Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants

Yudong Su, Xiang Long, Yang Song, Peng Chen, Shanqing Li, Huaxia Yang, Pancheng Wu, Yanyu Wang, Zhongxing Bing, Zhili Cao, Lei Cao, Yijun Wu, Zhe Zhang, Jing Liu, Bing Li, Jianxing Xiang, Ke Ma, Tengfei Zhang, Lu Zhang, Xinru Mao, Hao Liu, Puyuan Xing, Naixin Liang

Journal: JOURNAL OF TRANSLATIONAL MEDICINE

Volume: ,

Medium Impact
2016Journal

Induction docetaxel and S-1 followed by concomitant radiotherapy with low-dose daily cisplatin in locally advanced head and neck carcinoma

Hye Ryun Kim, Chang Geol Lee, Eun Chang Choi, Joo Hang Kim, Yoon Woo Koh, Byoung Chul Cho

Journal: HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Volume: ,

Low Impact
2016Journal

Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02)

Ji Yun Lee, Xu Qing, Wei Xiumin, Bai Yali, Sangah Chi, So Hyeon Bak, Ho Yun Lee, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Eun Kyung Cho, Dong-Wan Kim, Hye Ryun Kim, Young Joo Min, Sin-Ho Jung, Keunchil Park, Mao Mao, Myung-Ju Ahn

Journal: ONCOTARGET

Volume: ,

Low Impact
2016Journal

Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus

Sun Min Lim, Hyung Soon Park, Sangwoo Kim, Sora Kim, Siraj M Ali, Joel R Greenbowe, In Seok Yang, Nak-Jung Kwon, Jae Lyun Lee, Min-Hee Ryu, Jin-Hee Ahn, Jeeyun Lee, Min Goo Lee, Hyo Song Kim, Hyunki Kim, Hye Ryun Kim, Yong Wha Moon, Hyun Cheol Chung, Joo-Hang Kim, Yoon-Koo Kang, Byoung Chul Cho

Journal: ONCOTARGET

Volume: ,

Low Impact
2016Journal

A randomized phase II trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancer

Su Jin Heo, Inkyung Jung, Choong-Kun Lee, Jee Hung Kim, Sun Min Lim, Yong Wha Moon, Hyo Sup Shim, Jaeheon Jeong, Joo-Hang Kim, Hye Ryun Kim, Byoung Chul Cho

Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY

Volume: ,

Low Impact
2016Journal

Clinical course of stage IV invasive mucinous adenocarcinoma of the lung

Yoon Jin Cha, Hye Ryun Kim, Hye-Jeong Lee, Byoung Chul Cho, Hyo Sup Shim

Journal: LUNG CANCER

Volume: ,

Medium Impact
2016Journal

ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer models

Han Na Kang, Se-Ho Kim, Mi Ran Yun, Hye Ryun Kim, Sun Min Lim, Min-Soo Kim, Kwang-Won Hong, Sung-Moo Kim, Hwan Kim, Kyoung-Ho Pyo, Hye Ji Park, Joo Yeun Han, Hyun A Youn, Ki-Hwan Chang, Byoung Chul Cho

Journal: LUNG CANCER

Volume: ,

Medium Impact
2016Journal

Alteration status and prognostic value of MET in head and neck squamous cell carcinoma

Cho YA, Kim EK, Heo SJ, Cho BC, Kim HR, Chung JM, Yoon SO

Journal: JOURNAL OF CANCER

Volume: ,

Low Impact
2016Journal

Pilot Study of a Next-Generation Sequencing-Based Targeted Anticancer Therapy in Refractory Solid Tumors at a Korean Institution

Park HS, Lim SM, Kim S, Kim S, Kim HR, Kwack K, Lee MG, Kim JH, Moon YW

Journal: PLOS ONE

Volume: ,

Low Impact
2016Journal

Targeted sequencing identifies genetic alterations that confer primary resistance to EGFR tyrosine kinase inhibitor (Korean Lung Cancer Consortium)

Sun Min Lim, Hye Ryun Kim, Eun Kyung Cho, Young Joo Min, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park, Byoung Chul Cho, Ji-Hyun Lee, Hye Cheol Jeong, Eun Kyung Kim, Joo-Hang Kim

Journal: ONCOTARGET

Volume: ,

Low Impact
2016Journal

Efficacy and safety of dovitinib in pretreated patients with advanced squamous non-small cell lung cancer with FGFR1 amplification: A single-arm, phase 2 study

Sung Hee Lim, Jong-Mu Sun, Yoon-La Choi, Hye Ryun Kim, Soomin Ahn, Ji Yun Lee, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Joo Hang Kim, Byoung Chul Cho, Myung-Ju Ahn

Journal: CANCER

Volume: ,

High Impact
2016Journal

Activation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapy

S-M Kim, H Kim, M R Yun, H N Kang, K-H Pyo, H J Park, J M Lee, H M Choi, P Ellinghaus, M Ocker, S Paik, H R Kim, B C Cho

Journal: ONCOGENESIS

Volume: ,

Medium Impact
2016Journal

Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative

Sun Min Lim, Eun Young Kim, Hye Ryun Kim, Siraj M Ali, Joel R Greenbowe, Hyo Sup Shim, Hyun Chang, Seungtaek Lim, Soonmyung Paik, Byoung Chul Cho

Journal: ONCOTARGET

Volume: ,

Low Impact
2016Journal

PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.

Hyo Song Kim, Seung Eun Lee, Yoon Sung Bae, Dae Joon Kim, Chang Geol Lee, Jin Hur, Hyunsoo Chung, Jun Chul Park, Sung Kwan Shin, Sang Kil Lee, Yong Chan Lee, Hye Ryun Kim, Young Mog Shim, Susan S Jewell, Hyunki Kim, Yoon La Choi, Byoung Chul Cho

Journal: ONCOTARGET

Volume: ,

Low Impact
2016Journal

Clinicopathological and prognostic significance of programmed cell death ligand-1 expression in lung adenocarcinoma and its relationship with p53 status.

Yoon Jin Cha, Hye Ryun Kim, Chang Young Lee, Byoung Chul Cho, Hyo Sup Shim

Journal: LUNG CANCER

Volume: ,

Medium Impact
2016Journal

Assessment of Adrenal Function and Health-Related Quality of Life in Advanced Gastric Cancer Patients Who Received First-Line Chemotherapy.

Hye Ryun Kim, Jee Hung Kim, Yumie Rhee, Hosun Lee, Seung Eun Song, Chan Kim, Sukyung Song, Sung Hoon Noh, Sun Young Rha

Journal: ONCOLOGY

Volume: ,

Low Impact

2015

10 publications
2015Journal

Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung Adenocarcinoma

Chan Woo Kang, Kang Won Jang, Jinyoung Sohn, Sung-Moo Kim, Kyoung-Ho Pyo, Hwan Kim, Mi Ran Yun, Han Na Kang, Hye Ryun Kim, Sun Min Lim, Yong Wha Moon, Soonmyung Paik, Dae Joon Kim, Joo Hang Kim, Byoung Chul Cho

Journal: MOLECULAR CANCER THERAPEUTICS

Volume: ,

Medium Impact
2015Journal

PD-1: Dual guard for immunopathology.

Hye Ryun Kim, Hyo Jin Park, Sang-Jun Ha

Journal: ONCOTARGET

Volume: ,

Low Impact
2015Journal

The Clinicopathologic Features and Prognostic Impact of ALK Positivity in Patients with Resected Gastric Cancer

Hong Jae Chon, Hye Ryun Kim, Eunah Shin, Chan Kim, Su Jin Heo, Choong-Kun Lee, Jin Kyu Park, Sung Hoon Noh, Hyun Cheol Chung, Sun Young Rha

Journal: ANNALS OF SURGICAL ONCOLOGY

Volume: ,

Medium Impact
2015Journal

Reduced expression of EI24 confers resistance to gefitinib through IGF-1R signaling in PC9 NSCLC cells

Jung-Min Choi, Ji-Young Jang, Yu-Ra Choi, Hye Ryun Kim, Byoung Chul Cho, Han-Woong Lee

Journal: LUNG CANCER

Volume: ,

Medium Impact
2015Journal

Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine

Choong-kun Lee, Minkyu Jung, Hye Jin Choi, Hye Ryun Kim, Hyo Song Kim, Mi Ryung Roh, Joong Bae Ahn, Hyun Cheol Chung, Su Jin Heo, Sun Young Rha, Sang Joon Shin

Journal: CANCER RESEARCH AND TREATMENT

Volume: ,

Medium Impact
2015Journal

An open label, multicenter, phase II study of dovitinib in advanced thyroid cancer

Sun Min Lim, Woong Youn Chung, Kee-Hyun Nam, Sang-Wook Kang, Jae Yun Lim, Hoon-Gu Kim, Seong Hoon Shin, Jong-Mu Sun, Seong-Geun Kim, Joo-Hang Kim, Chan Woo Kang, Hye Ryun Kim, Byoung Chul Cho

Journal: EUROPEAN JOURNAL OF CANCER

Volume: ,

Medium Impact
2015Journal

The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancer

Ji Soo Park, Jae-Seok Lee, Eun Young Kim, Ji Ye Jung, Se Kyu Kim, Joon Chang, Dae Joon Kim, Chang Young Lee, Inkyung Jung, Joo Hang Kim, Hye Ryun Kim, Yong Wha Moon, Hyo Song Kim, Byoung Chul Cho, Hyo Sup Shim

Journal: LUNG CANCER

Volume: ,

Medium Impact
2015Journal

Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma.

Dong Wang, Licheng Du, Zhou Wang, Xiangyan Liu, Yejun Qin, Qiangxiu Wang, Zhe Yang, Zhigang Yao, Mo Shi, Bin Shang, Yang Jia, Huaxia Chen, Liang Qiao, Xueqing Wang, Zhaohua Xiao, Zhenchuan Liu

Journal: ONCOTARGET

Volume: ,

Low Impact
2015Journal

Phase II clinical and exploratory biomarker study of dacomitinib in patients with recurrent and/or metastatic squamous cell carcinoma of head and neck

Aldéric M Fraslin, Anne Aupérin, Caroline Even, Jérôme Fayette, Esma Saada-Bouzid, Cédrik Lafond, Lionnel Geoffrois, Jean Bourhis, Joël Guigay, Julia Bonastre

Journal: CLINICAL CANCER RESEARCH

Volume: ,

High Impact
2015Journal

Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma

Fei Yan, Jingni Zhu, Qibing Wu, Yuanyuan Ren, Xinnian Yu, Zijian Sun, Yang Liu, Changjiang Sun, Yan Sun

Journal: ONCOTARGET

Volume: ,

Low Impact

2014

7 publications
2014Journal

A prospective phase II trial of s-1 and cisplatin-based chemoradiotherapy for locoregionally advanced esophageal cancer

Hyun Chang, Sung Kwan Shin, Byoung Chul Cho, Chang-Geol Lee, Choong Bai Kim, Dae Joon Kim, Jin Gu Lee, Jin Hur, Chang Young Lee, Mi Kyung Bae, Hye Ryun Kim, Sang Kil Lee, Jun Chul Park, Hyuk Lee, Hyoung-Il Kim, Hyunsoo Chung, Jihye Cha, Yong Chan Lee, Joo-Hang Kim

Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY

Volume: ,

Low Impact
2014Journal

Prediction for response duration to epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR mutated never smoker lung adenocarcinoma

Hye Ryun Kim, Byoung Chul Cho, Hyo Sup Shim, Sun Min Lim, Se Kyu Kim, Joon Chang, Dae Joon Kim, Joo Hang Kim

Journal: LUNG CANCER

Volume: ,

Medium Impact
2014Journal

Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with renal insufficiency

Melissa Bersanelli, Francesco Facchinetti, Marcello Tiseo, Mariarosa Maiorana, Sebastiano Buti

Journal: EUROPEAN JOURNAL OF CANCER

Volume: ,

Medium Impact
2014Journal

Screening of ROS1 rearrangements in lung adenocarcinoma by immunohistochemistry and comparison with ALK rearrangements

Diane Frankel, Isabelle Nanni, L'Houcine Ouafik, Clara Camilla, Eric Pellegrino, Nathalie Beaufils, Laurent Greillier, Hervé Dutau, Philippe Astoul, Elise Kaspi, Patrice Roll

Journal: PLOS ONE

Volume: ,

Low Impact
2014Journal

Identification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokers

Jin Woo Ahn, Han Sang Kim, Jung-Ki Yoon, Hoon Jang, Soo Min Han, Sungho Eun, Hyo Sup Shim, Hyun-Jung Kim, Dae Joon Kim, Jin Gu Lee, Chang Young Lee, Mi Kyung Bae, Kyung Young Chung, Ji Ye Jung, Eun Young Kim, Se Kyu Kim, Joon Chang, Hye Ryun Kim, Joo Hang Kim, Min Goo Lee, Byoung Chul Cho, Ji Hyun Lee, Duhee Bang

Journal: GENOME MEDICINE

Volume: ,

High Impact
2014Journal

Impact of cigarette smoking on response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutations

Yoon Ki Cha, Ho Yun Lee, Myung-Ju Ahn, Keunchil Park, Jin Seok Ahn, Jong-Mu Sun, Yoon-La Choi, Kyung Soo Lee

Journal: LUNG CANCER

Volume: ,

Medium Impact
2014Journal

Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinoma

Yan Jin, Ping-Li Sun, Hyojin Kim, Eunhyang Park, Hyo Sup Shim, Sanghoon Jheon, Kwhanmien Kim, Choon-Taek Lee, Jin-Haeng Chung

Journal: LUNG CANCER

Volume: ,

Medium Impact

2013

9 publications
2013Journal

Phase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancer

Seungtaek Lim, Byoung Chul Cho, Ji Ye Jung, Gun Min Kim, Se Hyun Kim, Hye Ryun Kim, Han Sang Kim, Sun Min Lim, Ji Soo Park, Jun Ho Lee, Darae Kim, Eun Young Kim, Moo Suk Park, Young Sam Kim, Se Kyu Kim, Joon Chang, Joo Hang Kim

Journal: LUNG CANCER

Volume: ,

Medium Impact
2013Journal

Multicentre phase II trial of bevacizumab combined with docetaxel–carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905)

H R Kim, K H Jung, S-A Im, Y-H Im, S Y Kang, K H Park, S Lee, S-B Kim, K-H Lee, J S Ahn, S I Kim, J H Sohn

Journal: ANNALS OF ONCOLOGY

Volume: ,

High Impact
2013Journal

The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma

Dara L Aisner, Lynette M Sholl, Lynne D Berry, Michael R Rossi, Heidi Chen, Junya Fujimoto, Andre L Moreira, Suresh S Ramalingam, Liza C Villaruz, Gregory A Otterson, Eric Haura, Katerina Politi, Bonnie Glisson, Jeremy Cetnar, Edward B Garon, Joan Schiller, Saiama N Waqar, Lecia V Sequist, Julie Brahmer, Yu Shyr, Kelly Kugler, Ignacio I Wistuba, Bruce E Johnson, John D Minna, Mark G Kris, Paul A Bunn, David J Kwiatkowski

Journal: ANNALS OF ONCOLOGY

Volume: ,

High Impact
2013Journal

Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients

Hye Ryun Kim, Hyung Soon Park, Woo Sun Kwon, Ji Hyun Lee, Yusuke Tanigawara, Sun Min Lim, Hyo Song Kim, Sang Jun Shin, Jung Bae Ahn, Sun Young Rha

Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY

Volume: ,

Low Impact
2013Journal

EGFR and TTF-1 Gene Amplification in Surgically Resected Lung Adenocarcinomas: Clinicopathologic Significance and Effect on Response to EGFR-Tyrosine Kinase Inhibitors in Recurred Cases

Jae Seok Lee, Hye Ryun Kim, Chang Young Lee, Mihwa Shin, Hyo Sup Shim

Journal: ANNALS OF SURGICAL ONCOLOGY

Volume: ,

Medium Impact
2013Journal

A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC)

Se Hyun Kim, Hyo Sup Shim, Jaeho Cho, Jae Heon Jeong, Sun Mi Kim, Yun Kyoung Hong, Ji Hee Sung, Sang-Jun Ha, Hye Ryun Kim, Hyun Chang, Joo Hang Kim, Crombet Tania, Byoung Chul Cho

Journal: LUNG CANCER

Volume: ,

Medium Impact
2013Journal

Role of FGF receptors as an emerging therapeutic target in lung squamous cell carcinoma

Lim SM, Kim HR, Shim HS, Soo RA, Cho BC

Journal: FUTURE ONCOLOGY

Volume: ,

Medium Impact
2013Journal

Fibroblast Growth Factor Receptor 1 Gene Amplification Is Associated With Poor Survival and Cigarette Smoking Dosage in Patients With Resected Squamous Cell Lung Cancer

Hye Ryun Kim, Dae Joon Kim, Dae Ryong Kang, Jin Gu Lee, Sun Min Lim, Chang Young Lee, Sun Young Rha, Mi Kyung Bae, Young Joo Lee, Se Hoon Kim, Sang-Jun Ha, Ross Andrew Soo, Kyung Young Chung, Joo Hang Kim, Ji Hyun Lee, Hyo Sup Shim, Byoung Chul Cho

Journal: JOURNAL OF CLINICAL ONCOLOGY

Volume: ,

High Impact
2013Journal

The Impact of Cigarette Smoking on the Frequency of and Qualitative Differences in KRAS Mutations in Korean Patients with Lung Adenocarcinoma

Hye Ryun Kim, Jung Ryun Ahn, Jin Gu Lee, Doo Hee Bang, Sang-Jun Ha, Yun Kyoung Hong, Sun Mi Kim, Ki Chang Nam, Sun Young Rha, Ross A Soo, Gregory J Riely, Joo Hang Kim, Byoung Chul Cho

Journal: YONSEI MEDICAL JOURNAL

Volume: ,

Low Impact

2012

5 publications
2012Journal

A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy

Sang Joon Shin, Joong Bae Ahn, Kyung Soo Park, Yoon Jung Lee, Yong Sang Hong, Tae Won Kim, Hye Ryun Kim, Sun Young Rha, Jae Kyung Roh, Dal-Hyun Kim, Chin Kim, Hyun Cheol Chung

Journal: INVESTIGATIONAL NEW DRUGS

Volume: ,

Low Impact
2012Journal

Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement

Tomohiro Yoshinari, Takeyuki Nagashima, Hiroki Ishioka, Kohei Inamura, Yoshihiro Nishizono, Mamoru Tasaki, Kanako Iguchi, Atsushi Suzuki, Chikako Sato, Ayako Nakayama, Yasushi Amano, Yukihiro Tateishi, Yosuke Yamanaka, Fumio Osaki, Masayasu Yoshino, Kazuyuki Kuramoto, Tomoyoshi Imaizumi, Masahiko Hayakawa

Journal: CANCER

Volume: ,

High Impact
2012Journal

A phase I pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapy

Sang Joon Shin, Minkyu Jung, Hei-Cheul Jeung, Hye Ryun Kim, Sun Young Rha, Jae Kyung Roh, Hyun Cheol Chung, Joong Bae Ahn

Journal: INVESTIGATIONAL NEW DRUGS

Volume: ,

Low Impact
2012Journal

Phase II study of cisplatin with irinotecan as induction chemotherapy followed by chemoradiotherapy for unresectable stage III non-small cell lung cancer

Hyun Chang, Se Hyun Kim, Byoung Chul Cho, Sang Hyun Yoon, Hye Ryun Kim, Chang Geol Lee, Joo Hang Kim

Journal: ANTICANCER RESEARCH

Volume: ,

Low Impact
2012Journal

The efficacy and toxicity of S-1 and cisplatin as first-line chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma

Kim HS, Kim HR, Kim GM, Kim HS, Koh YW, Kim SH, Choi EC, Hong YK, Sung JH, Kim SM, Kim JH, Cho BC

Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY

Volume: ,

Low Impact

2011

2 publications
2011Journal

Treatment of recurrent hepatocellular carcinoma after liver transplantation

Wei-Chen Lee, Chih-Hsien Cheng, Tsung-Han Wu, Yu-Chao Wang, Jin-Chiao Lee, Hao-Chien Hung, Chen-Fang Lee, Ting-Jung Wu, Hong-Shiue Chou, Kun-Ming Chan

Journal: ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Volume: ,

Low Impact
2011Journal

Efficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasis

Nicholas A Bosma, Alysha R Keehn, Richard Lee-Ying, Safiya Karim, Anthony R MacLean, Darren R Brenner

Journal: ONCOLOGY

Volume: ,

Low Impact

2010

1 publication
2010Journal

Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinoma

Jiyang Li, Hongqing Xi, Jianxin Cui, Kecheng Zhang, Yunhe Gao, Wenquan Liang, Aizhen Cai, Bo Wei, Lin Chen

Journal: INTERNATIONAL JOURNAL OF HYPERTHERMIA

Volume: ,

Low Impact

2009

5 publications
2009Journal

Prognosis of pN3 stage gastric cancer

Guangmin Wan, Quan Wang, Lu Yang, Gang Xu

Journal: CANCER RESEARCH AND TREATMENT

Volume: ,

Medium Impact
2009Journal

Docetaxel versus paclitaxel combined with 5-FU and leucovorin in advanced gastric cancer: combined analysis of two phase II trials.

Hong Jae Chon, Sun Young Rha, Chong Kun Im, Chan Kim, Min Hee Hong, Hye Ryun Kim, Jung Ryun An, Sung Hoon Noh, Hyun Cheol Chung, Hei-Cheul Jeung

Journal: CANCER RESEARCH AND TREATMENT

Volume: ,

Medium Impact
2009Journal

Tension pneumopericardium after removal of pericardiocentesis drainage catheter

Hye Ryun Kim, Donghoon Choi, Joo Won Chung, Young Nam Youn, Chi Young Shim

Journal: CARDIOLOGY JOURNAL

Volume: ,

Low Impact
2009Journal

Clinical features and treatment outcomes of advanced stage primary hepatic angiosarcoma

H R Kim, S Y Rha, S H Cheon, J K Roh, Y N Park, N C Yoo

Journal: ANNALS OF ONCOLOGY

Volume: ,

High Impact
2009Journal

Clinical value of ezrin expression in primary osteosarcoma

Iwona Lugowska, Ewa Mierzejewska, Malgorzata Lenarcik, Teresa Klepacka, Irena Koch, Elzbieta Michalak, Katarzyna Szamotulska

Journal: CANCER RESEARCH AND TREATMENT

Volume: ,

Medium Impact

2007

1 publication
2007Journal

Transthoracic Echocardiographic Detection, Differential Diagnosis, and Follow-Up of Esophageal Hematoma

Im E, Shim CY, Hwang HJ, Lee SY, Yang WI, Jung YS, Kim HR, Choi EY, Ha JW, Chung N

Journal: KOREAN CIRCULATION JOURNAL

Volume: ,

Low Impact

Research Impact

📊

Citations

Our research has been cited over 2,500 times, demonstrating significant impact in the field.

🏆

Awards

Multiple publications have received best paper awards and recognition from professional societies.

🌍

Global Reach

Collaborations with researchers from over 15 countries, fostering international scientific exchange.

Complete Publication List

For the most up-to-date list of publications and citation metrics, please visit our Google Scholar profile.

View Google Scholar Profile